Catalyst Wire Dossier Catalyst Wire Dossier

TRIV-509

· Triveni Bio
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRIV-509, covering 2026-04-02 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating TRIV-509 in Atopic Dermatitis [Phase 2]

See pricing